Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?

Area of Science:

• Obstetrics and Gynecology
• Vascular Biology
• Pathophysiology

Background:

• Pre-eclampsia (PE) is characterized by endothelial dysfunction, a key pathogenic factor.
• Endothelial dysfunction involves immune activation altering endothelial cells and the endothelial glycocalyx (eGC).
• The eGC regulates vascular tone and thromboresistance, functions disrupted in PE.

Purpose of the Study:

• To explore the role of endothelial glycocalyx (eGC) alterations in the pathogenesis of pre-eclampsia (PE).
• To propose targeting eGC damage as a novel therapeutic strategy for PE.

Main Methods:

• Review of existing literature on endothelial dysfunction and PE.
• Analysis of the role of eGC in endothelial cell function and PE pathology.

Main Results:

• Studies indicate eGC components undergo alterations in pathological conditions, including PE.
• eGC damage is implicated in the disruption of endothelial cell functions relevant to PE.
• Alterations in eGC are hypothesized to play a significant role in PE pathogenesis.

Conclusions:

• Viewing eGC damage as central to PE pathogenesis may open new avenues for prevention and treatment.
• Developing drugs that protect and regenerate the eGC could be a valuable therapeutic approach for PE patients.